Weekly Recap

AMX0035 NDA Planned, gammaCore Approved to Treat Paroxysmal Hemicrania, Epilepsy Represents Risk Factor for SUD

September 18, 2021

Neurology News Network for the week ending September 18, 2021.

Joint Mobilization Exercises Improve Systemic Sclerosis Spasticity, Ocrelizumab Long-Term Safety, Antiplatelets Non-Effect on Recurrent ICH

September 11, 2021

Neurology News Network for the week ending September 11, 2021.

Salt Substitutes Reduce Stroke Risk, Access to Rehab Disrupted by COVID-19, Headache Infusion Centers Limited

September 04, 2021

Neurology News Network for the week ending September 4, 2021.

Fingolimod Preserves MS Cognition, Ravulizumab ALS Trial Discontinued, ADVANCE Results Published

August 28, 2021

Neurology News Network for the week ending August 28, 2021.

ACTH Superior to Treat Infantile Spasms, SESI-HRMS Serves as Viable OSA Screening Tool, Myeloid Microvesicles Diagnostic Value in MS

August 21, 2021

Neurology News Network for the week ending August 21, 2021.

DTAS Leads to Improved Stroke Outcomes, FDA Approves Avalglucosidase Alfa, No Evidence of Suicidality in ASMs

August 14, 2021

Neurology News Network for the week ending August 14, 2021.

Seizure Detection Using Machine Learning, Seroconversion Rate Lower in Anti-CD20 Therapies, Age of Diabetes Onset Correlated With Dementia

August 07, 2021

Neurology News Network for the week ending August 7, 2021.

Cenobamate Shows High Retention, Increased Risk of Depression in MS, DAPT Therapy Benefits Moderate Ischemic Stroke

July 24, 2021

Neurology News Network for the week ending July 24, 2021.

Starstim Device Granted Breakthrough Designation, Natalizumab Reduces Postpartum Relapse Risk, EFRONT Dementia Study Announced

July 17, 2021

Neurology News Network for the week ending July 17, 2021.

Narcolepsy Severity Scale Shows Benefit, Amantadine Improves Daily Living, Pridopidine's Neuroprotective Properties

July 10, 2021

Neurology News Network for the week ending July 10, 2021.